PSE
At the 2017 Advanced Process Modelling (APM) Forum in London this week, companies from across the process industries presented on topics ranging from accelerating development of the next generation of drugs to identifying millions of dollars per annum in operational savings.
Organised and hosted by Process Systems Enterprise (PSE), providers of the gPROMS APM platform, the two-day conference is a key annual event for process industry organisations focused on creating sustainable value through the application of high-accuracy predictive process modelling and optimisation.
Keynote speaker Jan van Schijndel of VS Strategic Consulting, formerly head of GTL development at Shell, outlined a vision for Operational Excellence capable of bringing $40-80m per annum improvements in process economics for large-scale petrochemical plants. Brian Henry, Vice President for Drug Product Design at Pfizer, described how digital design techniques that draw on technologies developed and proven in other areas are changing the way the industry develops and manufactures drugs, based on a fundamental understanding of process and product performance.
In the formulated products sessions, aimed at the pharmaceuticals, food & beverage and consumer goods sectors, presentations from GSK, Roche, AstraZeneca, Dr Reddy’s, Eli Lilly, Procter & Gamble, Danone and FrieslandCampina described the application of advanced mechanistic modelling in improving drug product manufacture, increasing food product throughput and reducing energy costs and CO2 footprint. New technologies such as global system analysis are now allowing manufacturers to systematically explore the decision space to an unprecedented degree. This accelerates innovation and significantly decreases time-to-market for new formulations. It also reduces process uncertainty, resulting in more robust processes.
Also at the Forum, PSE and Dutch food research organisation NIZO announced the formation of a Centre of Excellence for Food Product & Process Modelling, and PSE provided a preview of the all-new gPROMS FormulatedProducts environment for integrated design and optimisation of formulated products and their manufacturing processes, scheduled for release in May.
In the chemicals, petrochemicals and energy & environment sessions, where presenters included Shell, Sabic, SCG Chemicals, DSM, Primetals and Velocys, the focus was again on the application of large-scale optimisation techniques to reduce operating costs or enhance product values to the tune of millions or tens of millions of dollars per year. The Oil & Gas session similarly focused on new multi-site and integrated asset optimisation approaches for maximising asset utilisation.
Conference organiser Mark Matzopoulos, PSE Marketing Director, said “a key takeaway of the conference is that the maturing of advanced process and materials modelling techniques and tools is making it increasingly easy for process organisations – whether pharma, food manufacture or petrochemicals – to deal with systems of enormous complexity. The increased understanding enables them to make better-informed decisions faster, resulting in competitive advantage and accelerated innovation”.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170428005849/en/
Contact:
Process Systems Enterprise
Kate Burness
+44-20-8563-0888
k.burness@psenterprise.com
Editors:
www.psenterprise.com/news/pr170428.html
Link:
Social Media:
https://www.facebook.com//Process-Systems-Enterprise-Limited-PSE-194030330653358/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Study from UK’s Largest Virtual ADHD Service Validates Role of Objective Testing in Delivering Personalized, High-Quality Remote ADHD Care10.5.2025 12:45:00 CEST | Press release
Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: New findings show significant improvements in access, clinician confidence, symptom tracking, and individualized care using objective testing. The study underscores the importance of scalable, evidence-based tools, as many countries, including both the UK and the US, face rising demand for ADHD diagnosis and treatment. The study revealed significant improvements post-treatment, validating clinical practice and better clinician-patient alignment. As demand for virtual ADHD care increases, findings from a new study conducted with ADHD 360, the UK’s largest evidence-based digital service specializing in ADHD diagnosis and treatment, reveal how objective ADHD diagnostic and monitoring technology improves patient outcomes and clinical certainty. Presented at the 2025 ADHD World Congress in Pra
Ant International Partners with Barclays on Global Treasury Management with Proprietary AI-Powered FX Model9.5.2025 15:57:00 CEST | Press release
The Time-Series Transformer AI FX Model forecasts cashflow and FX exposure with more than 90% accuracy, helping businesses reduce FX-related fees Ant International has entered a partnership with leading UK bank Barclays to enhance efficiency and resilience in global treasury management for businesses. Under the partnership, the two sides will combine innovative solutions, including Ant’s proprietary Time-Series Transformer (TST) AI FX Model, to help businesses reduce FX-related costs and risks against global volatilities. At the initial stage of the collaboration, Ant International has successfully completed the first batch of its intra-group FX transactions with Barclays. Ant International’s TST Model is a transformer architecture-based big data model with close to 2 billion parameters. By integrating the latest time series forecasting algorithms, the TST Model predicts patterns over time. Ant also created new pre-training and Supervised Fine-Tuning (SFT) frameworks to train the model
IFF Completes Divestiture of Nitrocellulose Business9.5.2025 14:00:00 CEST | Press release
IFF (NYSE: IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The business manufactures nitrocellulose strictly for industrial purposes, serving customers primarily in coatings and printing inks, and had been part of IFF’s Pharma Solutions business unit. “The divestiture of our nitrocellulose business builds upon our deleveraging journey and enables us to focus on our core businesses,” said Erik Fyrwald, IFF CEO. “I’d like to thank our nitrocellulose colleagues for their dedication and wish them continued success as part of CSG.” Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Le
Monument Re Transfers €1.4bn Greycastle Portfolio to RGA and Strengthens European Life Insurance Consolidation Platform9.5.2025 14:00:00 CEST | Press release
Monument Re Limited (“Monument”) announces today that it has transferred a legacy €1.4bn reinsurance portfolio, comprising annuity and other life insurance liabilities acquired as part of the 2020 Greycastle transaction, to RGA Americas Reinsurance Company, Ltd. (“RGA”). This transaction releases capital resources that Monument will redirect to its core strategy of consolidation in European life insurance markets. The transaction completed on 2May 2025 following approval by the Boards of Directors of both Monument and RGA and non-objection from the Bermuda Monetary Authority. Monument has taken significant steps in recent months to strengthen its business operations by consolidating its European group support functions in Dublin and by aligning with the recently strengthened regulatory regime in Bermuda. With its strong financial position and best in class capabilities in the Group, Monument remains ideally positioned to build on its success to date and grow its European footprint, del
CPAC Systems AB Announces Strategic Minority Investment in Flying Fish9.5.2025 12:33:00 CEST | Press release
Accelerating the shift toward sustainable and intelligent water mobility CPAC Systems AB, a leader in advanced control systems and embedded vessel and commercial vehicle technology, today announced a strategic minority investment in Flying Fish Maritime Innovations B.V., a pioneer in advanced shared water mobility solutions and robust, cost-effective hydrofoil technology. The investment underscores both companies’ commitment to redefining water-based transportation through innovation, sustainability, and seamless integration. It marks the beginning of a deeper collaboration aimed at enabling smarter, cleaner, and more connected mobility on the water — for both recreational and commercial applications. “We are thrilled to support Flying Fish and their impressive work in redefining water mobility,"saidMarcus Wingolf, CEO of CPAC Systems. "Our investment in Flying Fish represents a strategic alignment of our technical proficiencies and innovative ambitions. This partnership opens exciting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom